NEW YORK, May 7-Massachusetts bioinformatics company AnVil said today that it has received two Small Business Innovation Research grants to develop software for cancer drug developers.
The grants were awarded by the National Institutes of Health for $99,225 and $98,328.
AnVil will use one grant to merge quantitative cluster comparison metrics with new visualization technologies. The company will then apply this new software tool to a National Cancer Institute compound data set.
With the second grant, AnVil will develop new high-dimensional visualization methods for data mining and cancer data analysis.
AnVil, based in Burlington, Mass., is privately owned.
For further information, see the company's website.